Trial Profile
A phase I study of ALB 127158A for the treatment of obesity.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Sep 2022
Price :
$35
*
At a glance
- Drugs ALB 127158A (Primary)
- Indications Obesity
- Focus Pharmacokinetics
- Sponsors AMRI; Curia
- 05 Oct 2011 New trial record
- 03 Oct 2011 Final results have been presented at the 29th Annual Scientific Meeting of the Obesity Society, according to an AMRI media release.